ÂÜÀòÂÒÂ×

Dana Alexander possesses extensive experience in the biopharmaceutical industry, currently serving as Chief Technical Officer at Obsidian Therapeutics. Previous roles include Senior Vice President of Technical Operations at AlloVir, Head of Business Operations for Viral Vector Services at Thermo Fisher Scientific, and Site Head/VP of Operations at Brammer Bio. Additionally, Dana held the position of Chief Operations Officer at Anika Therapeutics. Educational credentials include an MBA in Business Administration from the Questrom School of Business at Boston University and a BS in Chemical Engineering from Northeastern University.